Detalhe da pesquisa
1.
S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability in multiple myeloma.
Haematologica
; 109(1): 256-271, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37470139
2.
Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis.
J Pathol
; 260(2): 112-123, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36807305
3.
Targeting the ß2 -adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism.
J Pathol
; 259(1): 69-80, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36245401
4.
The antigen-binding moiety in the driver's seat of CARs.
Med Res Rev
; 42(1): 306-342, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34028069
5.
Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions.
Int J Mol Sci
; 23(2)2022 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35055096
6.
A niche-dependent myeloid transcriptome signature defines dormant myeloma cells.
Blood
; 134(1): 30-43, 2019 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31023703
7.
The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma.
Br J Cancer
; 120(12): 1137-1146, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31089208
8.
Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation.
J Pathol
; 241(4): 534-546, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27976373
9.
Metabolic Features of Multiple Myeloma.
Int J Mol Sci
; 19(4)2018 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29662010
10.
Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression.
J Pathol
; 239(2): 162-73, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26956697
11.
Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization.
Front Immunol
; 15: 1389018, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38720898
12.
AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia.
Theranostics
; 14(7): 2656-2674, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38773967
13.
Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo.
Acta Pharmacol Sin
; 34(5): 699-709, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23564084
14.
Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma.
J Immunother Cancer
; 11(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36650020
15.
RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma.
Front Immunol
; 14: 1286700, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38035078
16.
Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia.
Blood Cancer J
; 13(1): 188, 2023 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38110349
17.
Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment.
Cell Rep
; 42(5): 112475, 2023 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37167967
18.
Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibition.
Haematologica
; 102(7): e266-e270, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28385777
19.
Metabolic cross-talk within the bone marrow milieu: focus on multiple myeloma.
Exp Hematol Oncol
; 11(1): 49, 2022 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36050788
20.
Aberrant DNA methylation in multiple myeloma: A major obstacle or an opportunity?
Front Oncol
; 12: 979569, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36059621